Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats

BACKGROUND: Irritable bowel syndrome (IBS) is a common chronic non-organic disease of the digestive system. Berberine (BBR) has been used to treat patients with IBS, but the underlying therapeutic mechanism is little understood. We believe that BBR achieves its therapeutic effect on IBS by preventin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Gastroenterol
Autors principals: Yu, Zhi-Chao, Cen, Yong-Xin, Wu, Ben-Hua, Wei, Cheng, Xiong, Feng, Li, De-Feng, Liu, Ting-Ting, Luo, Ming-Han, Guo, Li-Liangzi, Li, Ying-Xue, Wang, Li-Sheng, Wang, Jian-Yao, Yao, Jun
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2019
Matèries:
Basic Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6689801/
https://ncbi.nlm.nih.gov/pubmed/31413530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i29.3956
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars